(800) 266-7207 investor@navf.net
Native American Venture Fund, LLC
  • Home
  • About Us
  • Invest Now
  • News
  • Contact Us
Select Page

Higher Reinfection Risk? Vaccine Resistant? NYC Drops New Report on COVID Variants

by navf admin | Oct 22, 2021 | News

By Jennifer Millman • Published April 13, 2021 NBC NEW YORK Full Story Health officials say they are looking into whether the Washington Heights variant causes a higher risk of reinfection by other variants or is more resistant to vaccines, but they know it’s...

Mutations could render current Covid vaccines ineffective in a year or less, epidemiologists warn

by navf admin | Oct 22, 2021 | News

By Holly Ellyatt CNBC Published MAR 30 2021 Full Story Mutations of the coronavirus could render current vaccines ineffective within a year, according to a survey of experts in 28 countries.Of those surveyed, almost a third gave a time frame of nine months or...

In race between vaccines and variants, Massachusetts may be seeing an ‘uncoupling’ of COVID-19 cases and deaths

by navf admin | Oct 22, 2021 | News

By Nik DeCosta-Klipa Boston.com April 13, 2021 Full Story Experts estimate that the three variants of concern now account for more than half of Massachusetts cases. Three highly infectious COVID-19 variants are now estimated to account for more than half of all...

COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough

by navf admin | Oct 22, 2021 | News

BY Rita Rubin, MA JAMA NETWORK  PUBLISHED March 17, 2021 Full Story As COVID-19 cases resulting from infection with SARS-CoV-2 variants accumulate in the US and around the world, one question looms large: How well do the COVID-19 vaccines developed so far protect...

How this more contagious virus variant became dominant in the U.S.

by navf admin | Oct 22, 2021 | News

BY SANJAY MISHRA NATIONAL GEOGRAPHIC  PUBLISHED APRIL 9, 2021 Full Story The B.1.1.7 strain is spreading among adults and kids, and experts say that’s another reason to get vaccinated, fast. The coronavirus variant known as B.1.1.7, which studies show is both...
« Older Entries
Next Entries »

Recent Posts

  • The Pandemic Is NOT Over
  • Omicron
  • Study: Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review
  • Study: Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous
  • Study: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes

Recent Comments

No comments to show.

Company

  • About Us
  • Meet Our Team
  • Invest Now
  • Latest News
  • Contact Us
  • Sitemap

Sponsors

Get in touch



30 Wall Street, 8th Floor New York, NY 10005



+1 212-634-4300



investor@navf.net

  • Follow

Copyright © 2023 Native American Venture Fund, LLC | Powered by Native American Venture Fund, LLC